UPC Analytics
ENDE
Overview · Filed: —

UPC_APP_32529/2025

BIOTELEMETRY DEVICE THAT CAN BE INGESTED AND IMPLANTED IN VIVO

AppealsEPO / Decision AppealMilan CDAction against the decision of the EPO (RoP97)—
OverviewDecisionsCitationsDocumentsTimeline
Parties

Claimants

  • Bodycap
  • Centre National de la Recherche Scientifique (CNRS)
  • Université de Rennes
Reps: Geoffroy Cousin (Novagraaf)

Respondents

  • EPO (Office européen des brevets)
Judges
  • Andrea PostiglioneDuty judge
Patents
  • EP 3 691 518
CPC codes: A61B5/0031, A61B5/0537, A61B5/0507, A61B5/073, A61B1/041, A61B5/07, A61B5/7225, A61B5/0538

Sector: Pharmaceutical & Medical

Outcome
Dismissed
Filed: —
First decided: Aug 6, 2025
Language: —

Order of Central Division Milan Section (duty judge, in French) dismissing Bodycap, CNRS and Université de Rennes' appeal (under R. 97 RoP) against the EPO's rejection of their unitary effect request for EP 3 691 518. The EPO had correctly applied R. 6.2 and R. 7.3 of the Implementing Regulations for Unitary Protection (RPU): after the university reorganisation (Université de Rennes I dissolved and replaced by Université de Rennes), the new address had not been provided in the unitary effect application within the one-month non-extendable deadline under R. 7.3 RPU. Each party bears its own costs.